RxDoctor Payments Data

Maryann Efesoa

Family · Bedford, TXNPI 1659703023

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 177 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,023 and has fallen 86.3% since, to $140 in 2024.

$2,953in general payments, 2019–2025

Across 177 payments — averaging $16.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$383
  • Abbott$260
  • GSK$259
  • Lilly USA, LLC$251
  • AbbVie$204
  • Johnson & Johnson$153
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$2,953100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,953 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.

See all family providers in Texas →

Other family in Bedford

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →